• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Marijuana Stocks To Watch - Tuesday, August 15th

August 15, 2017

 

Based on recent news and market action in early trading, here are a few marijuana stocks to watch in the rest of today's market day. Happy Trading!

 

Aero Grow International Inc. (OTC:AERO) 

 

Shares of Aero Grow are up roughly 0.5% in early trading. Volume is already higher than the company's 30-day average volume. After the close of trading yesterday, Aero Grow announced the company's earnings for the quarter ended June 30, 2017. Revenues increased 14% from the first quarter of last year, but operating losses also rose compared to last year's Q1. We'll be watching to see how the market continues to digest this mixed earnings release from Aero Grow. 

 

Related: 3 ETFs With Significant Exposure to Scotts Miracle-Gro (Scotts has a significant stake in Aero Grow)

 

Aphria Inc. (TSX:APH)(OTC:APHQF)(FRA:10E)

 

Earlier this morning, Aphria announced that the company is making a $11.5 million CAD investment in Scientus Pharma. Scientus Pharma is a Canadian licensed dealer and developer of cannabinoid based biopharmaceuticals. In midday trading on the Frankfurt exchange, shares of Aphria are rising by more than 2%. On the TSX, Aphria is up roughly 1% in early trading. We'll be watching to see how the markets continue to react to this news of Aphria's latest investment. 

 

Related: Aphria Enters into Strategic Partnership with Int'l Cannabis Company, Nuuvera

 

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) 

 

Shares of Zynerba are falling roughly 1.5% in early trading after getting hit with two major analyst downgrades. Oppenheimer downgraded Zynerba to Perform from Outperform and Jefferies downgraded ZYNE shares from Buy to Hold. On Monday, Zynerba announced that the company's cannabidiol gel failed to meet its primary endpoint (although it did meet secondary endpoints) in their phase two trial for knee osteoarthritis. The markets are continuing to ponder the potential causes of these not so great clinical trial results and what it means for Zynerba, as well as synthetic cannabinoids and alternate drug delivery methods more broadly. 

 

Related: 7 Things to Know About Zynerba's Pipeline & Q2 Earnings Release

 

 Conclusion
 
That's all for now, but we'll be sure to keep readers posted regarding important developments in these names and in the cannabis industry worldwide. Be sure to subscribe to one or more of our free newsletters so you never miss an important marijuana update. Don't be a stranger, connect with The Daily Marijuana Observer on FacebookTwitterStockTwits and Instagram!
 

 

D/M/O

 

Disclaimer
 
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor. 

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.